We are live on
!
Find out more
WSTAM
Wilbanks Smith & Thomas Asset Management Portfolio holdings
AUM
$3.57B
1-Year Est. Return
21.11%
This Fund
S&P 500
This Quarter
Est. Return
+5.49%
1 Year Est. Return
+21.11%
3 Year Est. Return
+25.24%
5 Year Est. Return
+75.04%
10 Year Est. Return
+189.02%
AUM
$3.03B
AUM Growth
+$149M
(+5.2%)
Cap. Flow
+$9.57M
Cap. Flow
% of AUM
0.32%
Top 10 Holdings %
Top 10 Hldgs %
35%
Holding
538
New
32
Increased
155
Reduced
238
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Treasury Bond ETF
GOVT
|
+$62.7M |
| 2 |
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
|
+$42.5M |
| 3 |
VanEck Fallen Angel High Yield Bond ETF
ANGL
|
+$31.5M |
| 4 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$26.1M |
| 5 |
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
|
+$18.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
|
+$52.8M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$49.3M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$27.7M |
| 4 |
Xtrackers USD High Yield Corporate Bond ETF
HYLB
|
+$25.6M |
| 5 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$15.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.59% |
| 2 | Industrials | 5.96% |
| 3 | Healthcare | 4.97% |
| 4 | Financials | 4.06% |
| 5 | Consumer Staples | 3.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Colgate-Palmolive
CL
$74.4B
| $1.21M | 0.04% |
15,668
+3,159
| +25% | +$245K |
|
202
iShares Floating Rate Bond ETF
FLOT
$10.5B
| $1.19M | 0.04% |
23,456
-59,598
| -72% | -$3.01M |
|
203
iShares Global Industrials ETF
EXI
$1.48B
| $1.18M | 0.04% |
9,847
-21,210
| -68% | -$2.44M |
|
204
Nike
NKE
$61.9B
| $1.18M | 0.04% |
10,670
-355
| -3% | -$41.5K |
|
205
Air Products & Chemicals
APD
$67.6B
| $1.17M | 0.04% |
3,892
-43
| -1% | -$12.2K |
|
206
Schwab US Large- Cap ETF
SCHX
$74.6B
| $1.16M | 0.04% |
66,486
+2,949
| +5% | +$48.7K |
|
207
Thermo Fisher Scientific
TMO
$220B
| $1.15M | 0.04% |
2,196
+82
| +4% | +$44.3K |
|
208
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.47B
| $1.14M | 0.04% |
24,261
-3,520
| -13% | -$166K |
|
209
JPMorgan Ultra-Short Income ETF
JPST
$40.6B
| $1.14M | 0.04% |
22,712
-7,671
| -25% | -$385K |
|
210
Cigna
CI
$74.6B
| $1.13M | 0.04% |
4,020
+433
| +12% | +$113K |
|
211
Comcast
CMCSA
$90B
| $1.1M | 0.04% |
26,354
+685
| +3% | +$27.2K |
|
212
Vanguard Short-Term Treasury ETF
VGSH
$30.2B
| $1.07M | 0.04% |
18,599
| – | – |
|
213
GE Aerospace
GE
$384B
| $1.06M | 0.03% |
12,035
-46
| -0.4% | -$3.73K |
|
214
iShares Core MSCI Emerging Markets ETF
IEMG
$156B
| $1.05M | 0.03% |
21,378
-1,782
| -8% | -$87K |
|
215
Goldman Sachs
GS
$303B
| $1.05M | 0.03% |
3,266
-149
| -4% | -$49K |
|
216
Eaton
ETN
$174B
| $1.03M | 0.03% |
5,146
-1,667
| -24% | -$293K |
|
217
Becton Dickinson
BDX
$48.2B
| $1.03M | 0.03% |
3,903
-501
| -11% | -$127K |
|
218
Starbucks
SBUX
$120B
| $1.03M | 0.03% |
10,402
-501
| -5% | -$52K |
|
219
CSX Corp
CSX
$93.1B
| $1.03M | 0.03% |
30,213
-2,102
| -7% | -$66.5K |
|
220
Vertex Pharmaceuticals
VRTX
$126B
| $1.02M | 0.03% |
2,904
-50
| -2% | -$16.8K |
|
221
West Pharmaceutical
WST
$24.9B
| $1.02M | 0.03% |
2,671
| – | – |
|
222
Progressive
PGR
$125B
| $1.02M | 0.03% |
7,695
-34
| -0.4% | -$4.56K |
|
223
Acuity Brands
AYI
$10.8B
| $1.01M | 0.03% |
6,219
-2
| -0% | -$319 |
|
224
JPMorgan Equity Premium Income ETF
JEPI
$45.9B
| $983K | 0.03% |
+17,773
| New | +$971K |
|
225
Vanguard Dividend Appreciation ETF
VIG
$114B
| $964K | 0.03% |
5,936
-1,035
| -15% | -$162K |
|
Similar funds
CW
ICG
CT
ZCM
CQS
SCM
AFIMH
DA
Wilbanks Smith & Thomas Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Wilbanks Smith & Thomas Asset Management held 538 positions worth $3.03B, up 5.2% from $2.88B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Wilbanks Smith & Thomas Asset Management's Q2 2023 filing shows 32 new, 155 increased, 238 reduced and 25 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 2,702,858 shares worth $61.9M. The largest sale was iShares iBonds Dec 2027 Term Corporate ETF, an estimated $52.8M.
By sector, the portfolio is most concentrated in Technology at 9.6% of assets, up from 8.6% a quarter earlier, followed by Industrials and Healthcare.
- Wilbanks Smith & Thomas Asset Management's largest Q2 2023 buy was iShares US Treasury Bond ETF: 2,702,858 shares worth $61.9M.
- Wilbanks Smith & Thomas Asset Management added most to VanEck Fallen Angel High Yield Bond ETF in Q2 2023, an estimated $31.5M increase.
- Wilbanks Smith & Thomas Asset Management's biggest Q2 2023 reduction was iShares iBonds Dec 2027 Term Corporate ETF, cutting an estimated $52.8M.
- Wilbanks Smith & Thomas Asset Management fully exited iShares Global Financials ETF in Q2 2023, selling an estimated $3.29M.
- Wilbanks Smith & Thomas Asset Management's ten largest holdings make up 35% of its $3.03B portfolio in Q2 2023.
- Wilbanks Smith & Thomas Asset Management opened 32 new positions and closed 25 in Q2 2023.
- Wilbanks Smith & Thomas Asset Management's portfolio value rose 5.2% quarter-over-quarter to $3.03B.
Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q2 2023, filed 8 Aug 2023.